EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

The Oncometabolite 2-Hydroxyglutarate Is Upregulated in Post-Prostatectomy PSA Recurrence of Prostate Cancer: A Metabolomic Analysis

Dontrel W Spencer Hairston, Shamira Sridharan-Weaver, Abheek Gandhi, Neelu Batra, Blythe P Durbin-Johnson, Marc A Dall'Era, Paramita M Ghosh iD

Molecules · 2025

DOI: 10.3390/molecules30163316 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecules, 2025. Verfasst von Dontrel W Spencer Hairston und 6 weiteren Autor:innen. Beteiligte Einrichtung: Veterans Affairs-Northern California Health System, Mather, CA 95655, USA. Hauptthemen laut MEDLINE: Prostatic Neoplasms, Prostate-Specific Antigen, Glutarates, Metabolomics. Die Arbeit nennt 60 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: BLRD VA, NCI NIH HHS, Department of Urologic Surgery, UC Davis (MAD).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

First-line treatment for localized prostate cancer (PCa) includes radical prostatectomy (RP) for high-risk disease. However, in many cases, patients experience biochemical recurrence (BCR), heralded by rising prostate specific antigen (PSA) levels in the serum. Our goal was to identify metabolic pathways that are disrupted in BCR to determine potential targets of therapy. We conducted metabolomic analysis in prostate tissue from the tumors of 74 patients who underwent prostatectomy as treatment for localized PCa and correlated levels of metabolites with clinical and non-clinical factors. Cholesterol and triglycerides were upregulated in Hispanic vs. non-Hispanic and in obese vs. non-obese individuals, respectively. Both lipids and non-lipids were altered with increasing Gleason grades and clinical stages. High post-RP PSA (>0.1 ng/mL) indicated recurrence (p = 0.0094) and correlated with alterations in 141 metabolites including 114 lipids and 26 non-lipid molecules. The largest increase with high post-RP PSA was in 2-hydroxyglutaric acid (2-HG), a product of the tricarboxylic acid (TCA) cycle, that had previously been established as an oncometabolite in other cancers. 2-HG was highly selective and specific for high post-RP PSA (AUC = 0.8526; p = 0.0002) while Kaplan–Meier curves indicated that among patients who recurred, high 2-HG in the tumor reduced time-to-recurrence from 84 months (for those with low 2-HG) to 38 months (for those with high 2-HG). The addition of D2HG, an enantiomer of 2-HG, increased the growth rate of LNCaP and C4 cells, and also increased Akt and ERK phosphorylation. 2-HG is upregulated in PCa tumors from patients who experience high post-RP PSA indicative of recurrence. Future studies may target this metabolite to prevent recurrent disease.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Prostatic NeoplasmsProstate-Specific AntigenGlutaratesMetabolomicsNeoplasm Recurrence, LocalHumansMaleProstatectomyMiddle AgedAgedUp-RegulationMetabolomeBiomarkers, Tumor

Stichwörter der Autor:innen

2-hydroxyglutaratePSAlocalized prostate cancerphospholipidstricarboxylic acid cycletriglycerides

Substanzen

Prostate-Specific AntigenGlutaratesalpha-hydroxyglutarateBiomarkers, Tumor

Autor:innen und Institutionen

  • Veterans Affairs-Northern California Health System, Mather, CA 95655, USA.
  • Department of Urologic Surgery, School of Medicine, University of California Davis, Sacramento, CA 95718, USA.
  • Department of Computer Science, University of California Irvine, Irvine, CA 92697, USA.
  • Department of Biochemistry and Molecular Medicine, School of Medicine, University of California Davis, Sacramento, CA 95718, USA.
  • Department of Public Health Sciences, University of California Davis, Davis, CA 95616, USA.

ORCID-Profile: Paramita M Ghosh

Förderung

  • BLRD VA
  • NCI NIH HHS
  • Department of Urologic Surgery, UC Davis (MAD)
  • Biomedical Laboratory Research & Development (BLRD) Merit Award
  • University of California Comprehensive Cancer Center Support Grant

Zitieren

APA

Hairston, D. W. S., Sridharan-Weaver, S., Gandhi, A., Batra, N., Durbin-Johnson, B. P., Dall'Era, M. A., & Ghosh, P. M. (2025). The Oncometabolite 2-Hydroxyglutarate Is Upregulated in Post-Prostatectomy PSA Recurrence of Prostate Cancer: A Metabolomic Analysis. Molecules. https://doi.org/10.3390/molecules30163316

Vancouver

Hairston DWS, Sridharan-Weaver S, Gandhi A, Batra N, Durbin-Johnson BP, Dall'Era MA, et al. The Oncometabolite 2-Hydroxyglutarate Is Upregulated in Post-Prostatectomy PSA Recurrence of Prostate Cancer: A Metabolomic Analysis. Molecules. 2025. doi:10.3390/molecules30163316

BibTeX
@article{Hairston2025,
  author = {Hairston, Dontrel W Spencer and Sridharan-Weaver, Shamira and Gandhi, Abheek and Batra, Neelu and Durbin-Johnson, Blythe P and Dall'Era, Marc A and Ghosh, Paramita M},
  title = {The Oncometabolite 2-Hydroxyglutarate Is Upregulated in Post-Prostatectomy PSA Recurrence of Prostate Cancer: A Metabolomic Analysis},
  journal = {Molecules},
  year = {2025},
  doi = {10.3390/molecules30163316}
}
Kostenlos starten →